BURLINGAME, Calif., Jan. 17, 2024 /PRNewswire/ — CoherentMI published a report, titled, Global Metagenomic Sequencing Market estimated value at US$ 1.41 Billion in the year 2023 and is anticipated to reach US$ 4.39 Billion by 2030, at a CAGR of 17.6% during forecast period 2023-2030.
The Global Metagenomic Sequencing Market is poised to experience significant growth, primarily driven by technological advancements. With the advent of next-generation sequencing (NGS) technologies and bioinformatics tools, metagenomic sequencing has become more efficient and cost-effective. NGS technologies enable the simultaneous sequencing of multiple DNA samples, allowing researchers to analyze the genetic composition of complex microbial communities on an unprecedented scale. This has considerably expanded the applications of metagenomic sequencing in various fields, including environmental monitoring, disease surveillance, and personalized medicine.
Furthermore, the increasing demand for accurate and rapid diagnostic solutions has also contributed to the market growth. Metagenomic sequencing offers a comprehensive genetic analysis of microbial communities, enabling healthcare professionals to identify and track potential pathogens. This enables better disease control and prevention strategies, leading to improved patient outcomes.
Key Market Takeaways:
Global Metagenomic Sequencing Market Size is anticipated to witness a CAGR of 17.6% during the forecast period 2023-2030, owing to the advancements in sequencing technology and the increasing demand for drug discovery applications.
On the basis of technology, the sequencing segment is expected to hold a dominant position, owing to its enhanced speed, accuracy, and cost-effectiveness compared to traditional sequencing methods.
On the basis of product, the instruments segment is expected to dominate, as they are essential for conducting metagenomic sequencing experiments.
On the basis of application, the drug discovery segment is expected to hold a dominant position, driven by the need for new antibiotics and personalized medicine.
On the basis of end-user, the pharmaceutical and biotechnology companies segment is expected to dominate, as they extensively utilize metagenomic sequencing for drug discovery and development.
In terms of region, North America is expected to hold a dominant position over the forecast period, due to the presence of a well-established healthcare infrastructure, increasing investments in research and development activities, and the presence of key market players in the region.
Key players operating in the Global Metagenomic Sequencing Market include Illumina, QIAGEN, Thermo Fisher Scientific, Oxford Nanopore Technologies, BGI Group, PerkinElmer, GENEWIZ, Macrogen, Zymo Research, Diversigen, Microsynth AG, BaseClear, MR DNA (Molecular Research), Eurofins Scientific, Novogene Corporation, NuGEN Technologies, Takara Bio, Swift Biosciences, New England Biolabs, and CosmosID. These key players contribute to the market growth through product developments, collaborations, and strategic partnerships.
Market Trends:
Two key trends shaping the Global Metagenomic Sequencing Market are as follows:
Rising applications in microbiome research: Metagenomic sequencing is increasingly being utilized in microbiome research to understand the role of microorganisms in human health and disease. It allows the identification and characterization of complex microbial communities, providing valuable insights into the interactions between microbes and their host. This has led to advancements in personalized medicine, where metagenomic sequencing can aid in the development of targeted therapies that leverage the microbiome’s potential.
Growing adoption in environmental monitoring: Metagenomic sequencing has emerged as a powerful tool for environmental monitoring and impact assessment. It enables the comprehensive analysis of microbial communities in various environments, such as water bodies, soil, and air. This helps in assessing ecosystem health, identifying potential sources of pollution, and developing effective environmental management strategies.
Recent Developments
On June 20 2023, Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, debuts with US$ 35 million in Series A financing led by Perceptive Xontogeny Venture Fund II (PXV Fund II) – and joined by Section 32 and GV. The funds will be used to commercialize the company’s mNGS-based infectious disease test – which was developed by world-renowned infectious disease experts at the University of California San Francisco (UCSF) Center for Next-Gen Precision Diagnostics – and advance a pipeline of next-generation tests.
In July 2022, Thermo Fisher Scientific, a biotechnology company, launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, an advanced digital PCR platform to provide ultra-sensitive quantification of nucleic acids.
Read complete market research report, “Global Metagenomic Sequencing Market Size And Share Analysis – Growth Trends And Forecasts (2023 – 2030)“, Published by CoherentMI.
Market Opportunities
Advancements in Sequencing Technology
The global metagenomic sequencing market is expected to witness significant growth opportunities due to advancements in sequencing technology. Sequencing is the dominating technology in this market segment, accounting for the largest share. The advent of next-generation sequencing (NGS) techniques has revolutionized metagenomic sequencing, enabling high-throughput analysis of microbial communities. NGS techniques offer enhanced speed, accuracy, and cost-effectiveness compared to traditional Sanger sequencing methods. This has led to increased adoption of metagenomic sequencing in various applications such as drug discovery, disease diagnosis, and environmental remediation. The continuous advancements in sequencing technology are expected to drive the growth of the global metagenomic sequencing market in the forecast period.
Increasing demand for Drug Discovery Applications
Another significant market opportunity in the global metagenomic sequencing market lies in the increasing demand for drug discovery applications. Metagenomic sequencing plays a crucial role in drug discovery by enabling the identification and analysis of microbial genomes and their functional characteristics. It helps in identifying novel bioactive compounds and potential drug targets, thereby accelerating the drug discovery process. The drug discovery segment is expected to dominate the application segment of the metagenomic sequencing market. Factors such as the increasing prevalence of chronic diseases, the need for new antibiotics, and the growing demand for personalized medicine are driving the demand for metagenomic sequencing in drug discovery. This presents a lucrative market opportunity for key players operating in the metagenomic sequencing market.
Global Metagenomic Sequencing Market Segmentation:
By Technology:
Sequencing
Bioinformatics
PCR
Microarray
Others
By Product:
Instruments
Reagents & Consumables
Services
Analysis Softwares
By Application:
Drug Discovery
Disease Diagnosis
Environmental Remediation
Gut Microbe Characterization
Others
By End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Agriculture & Biofuel Companies
Hospitals & Clinics
Others
By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa
Buy this premium report now @ https://www.coherentmi.com/industry-reports/global-metagenomic-sequencing-market/buyNow
Top Questions Answered in this Report:
What factors are impeding the growth of the Global Metagenomic Sequencing Market?
What are the primary drivers fueling the growth of the Global Metagenomic Sequencing Market?
Which segment dominates as the leading component in the Global Metagenomic Sequencing Market?
Who are the key players actively participating in the Global Metagenomic Sequencing Market?
Which region is expected to take the lead in the Global Metagenomic Sequencing Market?
What is the projected CAGR of the Global Metagenomic Sequencing Market?
Find More Trending Reports Below:
U.S. Fast Fashion Market is Segmented By Product Type (Clothing, Footwear, Accessories, Others), By End User (Men, Women, Unisex, Kids), By Price Range (Low, Medium, High), By Distribution Channel (Online, Company Outlets, Multi-brand Stores, Others). The report offers the value (in USD billion) for the above-mentioned segments.
India Ethanol Market is Segmented By Source (Molasses, Sugar Cane Juice, Grains, Others), By End User (Fuel, Industrial Solvents, Beverages, Cosmetics, Pharmaceuticals, Automotive, Others), By Grade (Denatured Alcohol, Undenatured Alcohol, Rectified Spirit, Specially Denatured Alcohol, Fuel Ethanol), By Blending (E5, E10, E15, E20, E25, E70, E85, E95), By Application Method (Starch-based, Sugar-based, Cellulosic), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
United States Pharmaceuticals Market is Segmented By Product Type (Prescription Drugs, Generic Drugs, OTC Drugs, Biologics, Biosimilars), By Therapy Area (Oncology, Diabetes, Autoimmune Diseases, Neurological Disorders, Cardiovascular, Infectious Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Oral, Parenteral, Topical), By End User (Hospitals, Clinics, Homecare Settings). The report offers the value (in USD billion) for the above-mentioned segments.
About Us:
At CoherentMI, we are a leading global market intelligence company dedicated to providing comprehensive insights, analysis, and strategic solutions to empower businesses and organizations worldwide. Moreover, CoherentMI is a subsidiary of Coherent Market Insights Pvt Ltd., which is a market intelligence and consulting organization that helps businesses in critical business decisions. With our cutting-edge technology and experienced team of industry experts, we deliver actionable intelligence that helps our clients make informed decisions and stay ahead in today’s rapidly changing business landscape.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
CoherentMI
Phone:
U.S.: +1-206-701-6702
U.K: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837
Email: [email protected]
Website: https://www.coherentmi.com
Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg
SOURCE Coherent Market Insights
